Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Gisbert

Showing results (121-130 of 317) with videos related to

Pageof 32
Sort By:
Revista Espanola De Enfermedades Digestivas|August 1, 1996
[Is gastric cancer an infectious disease?]J P Gisbert, D Boixeda, C Martín de Argila
Alimentary Pharmacology & Therapeutics|March 5, 2015
Editorial: quadruple therapy for H. pylori eradication is better than triple therapy - authors' replyJ Molina-Infante, D Y Graham, J P Gisbert
Alimentary Pharmacology & Therapeutics|January 30, 2015
Letter: Thiopurine withdrawal during sustained clinical remission in inflammatory bowel diseaseJ M Benítez, V García-Sánchez, J P Gisbert
Alimentary Pharmacology & Therapeutics|June 26, 2001
What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysisX Calvet, E Gené, T López, et al.
Alimentary Pharmacology & Therapeutics|May 20, 2003
Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysisE Gené, X Calvet, R Azagra, et al.
Medicina Clinica|March 11, 1998
[Infection by Helicobacter pylori: where is the limit?]J P Gisbert, D Boixeda, C Martín de Argila
Alimentary Pharmacology & Therapeutics|April 17, 2014
Letter: distinguishing PPI-responsive oesophageal eosinophilia from eosinophilic oesophagitis - still a long way to goJ Molina-Infante, E S Dellon, J P Gisbert
Alimentary Pharmacology & Therapeutics|May 20, 2008
Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patientsJ P Gisbert, P Niño, C Cara, et al.
Gastroenterologia Y Hepatologia|June 19, 2002
[Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease]J P Gisbert, F Gomollón, J Maté, et al.
Revista Espanola De Enfermedades Digestivas|November 1, 2001
Geographic differences and the role of cagA gene in gastroduodenal diseases associated with Helicobacter pylori infectionT Valmaseda Pérez, J P Gisbert, J M Pajares García
Pageof 32

Showing results (121-130 of 317) with videos related to

Sort By:
Pageof 32
Revista Espanola De Enfermedades Digestivas|August 1, 1996
[Is gastric cancer an infectious disease?]J P Gisbert, D Boixeda, C Martín de Argila
Alimentary Pharmacology & Therapeutics|March 5, 2015
Editorial: quadruple therapy for H. pylori eradication is better than triple therapy - authors' replyJ Molina-Infante, D Y Graham, J P Gisbert
Alimentary Pharmacology & Therapeutics|January 30, 2015
Letter: Thiopurine withdrawal during sustained clinical remission in inflammatory bowel diseaseJ M Benítez, V García-Sánchez, J P Gisbert
Alimentary Pharmacology & Therapeutics|June 26, 2001
What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysisX Calvet, E Gené, T López, et al.
Alimentary Pharmacology & Therapeutics|May 20, 2003
Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysisE Gené, X Calvet, R Azagra, et al.
Medicina Clinica|March 11, 1998
[Infection by Helicobacter pylori: where is the limit?]J P Gisbert, D Boixeda, C Martín de Argila
Alimentary Pharmacology & Therapeutics|April 17, 2014
Letter: distinguishing PPI-responsive oesophageal eosinophilia from eosinophilic oesophagitis - still a long way to goJ Molina-Infante, E S Dellon, J P Gisbert
Alimentary Pharmacology & Therapeutics|May 20, 2008
Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patientsJ P Gisbert, P Niño, C Cara, et al.
Gastroenterologia Y Hepatologia|June 19, 2002
[Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease]J P Gisbert, F Gomollón, J Maté, et al.
Revista Espanola De Enfermedades Digestivas|November 1, 2001
Geographic differences and the role of cagA gene in gastroduodenal diseases associated with Helicobacter pylori infectionT Valmaseda Pérez, J P Gisbert, J M Pajares García
Pageof 32